Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine.
Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine.
复制标题
DOI:
10.1097/psy.0000000000000223
复制
发表时间:
2015-07
影响因子:
3.3
通讯作者:
Ryan JP
中科院分区:
文献类型:
--
作者:
Everson-Rose SA;Ryan JP
Diabetes and obesity, two major public health concerns, are associated with increased risk for problems in multiple organ systems, including the central nervous system. The adverse effects of diabetes and obesity on cognitive functioning are increasingly well recognized. This special issue of Psychosomatic Medicine features the latest research linking diabetes, obesity and brain structure, function and metabolism and follows a special meeting on this topic organized by the American Psychosomatic Society in October 2013. Evidence for the increased prevalence of diabetes and obesity is reviewed as it relates to cognitive decline. These papers indicate that the age of onset of Type 1 diabetes may be relevant to future cognitive function and that disease duration of Type 2 diabetes as well as sociocultural factors are related to cognitive decline during the aging process. The hypothalamus and other neural circuits, notably the dopaminergic system that underlies feeding and reward-related aspects of food intake, are among the key factors involved in obesity. Research on the associations between obesity and cognitive function is described using the positive effects of weight reduction following bariatric surgery or behavioral methods. This issue concludes with a conceptual framework for linking obesity and diabetes with accelerated cognitive decline as related to the aging process. The collection of papers highlights the importance of using a lifespan perspective to understand the influence of both Type1 and Type 2 diabetes on brain metabolism, function and structure. Moreover, these studies show that distressing environmental circumstances can adversely influence neurocognitive processes in obesity and diabetes.